Company intelligence / Profile preview

Galepharm

Küsnacht, Zurich, Switzerland
Ownership
Private
Employees
~20
Development stage
Other
01

Overview

Galepharm is a Swiss pharmaceutical company headquartered in Küsnacht, specializing in the marketing and distribution of specialty medicines with a core focus on endocrinology. The company is a key provider of thyroid hormone replacement therapies, most notably Tirosint (levothyroxine), which is formulated as a liquid-filled softgel capsule to enhance bioavailability and consistency. Galepharm works closely with manufacturing partners like IBSA Institut Biochimique SA to bring innovative delivery forms of established molecules to the Swiss and European markets. Their business model centers on providing high-quality, reliable treatments for chronic conditions, particularly those requiring precise hormonal regulation. Additionally, Galepharm emphasizes clean formulations that are free from common allergens such as gluten and lactose, catering to patients with specific sensitivities.

Therapeutic areas
OncologyEndocrinology
Modalities
Small moleculeHormone
Industry
Biotech
02

Partnerships

IBSA Institut Biochimique SA

Beyond the preview

Go deeper on Galepharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galepharm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call